The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study

Karen Minde Fagerli; Elisabeth Lie; Désirée van der Heijde; Marte Schrumpf Heiberg; Åse Stavland Lexberg; Eric Rødevand; Synøve Kalstad; Knut Mikkelsen; Tore K Kvien

doi:10.1136/annrheumdis-2012-202347

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Clinical and epidemiological research

Extended report

The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Fagerli KM, Lie E, van der Heijde D, et al

The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study

Annals of the Rheumatic Diseases 2014;73:132-137.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password